Month: February 2026

Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute

Written by Customer Service on February 9, 2026. Posted in Public Companies.

PITTSBURGH, Feb. 09, 2026 (GLOBE NEWSWIRE) — Axe Compute (or the “Company”) (Nasdaq: AGPU) today announced the appointment of Christopher Miglino as Chief Executive Officer, marking a pivotal development in the company’s commitment to decentralized compute and digital infrastructure, operating at the intersection of blockchain, AI, and capital markets. Mr. Miglino transitions into the CEO role following his involvement in the structuring of Axe Compute’s digital asset treasury and the transaction resulting in the Company’s entry to the AI Compute market. His appointment reflects AGPU’s commitment to growing its compute platform. The Company plans to develop an institutionalized platform, supporting decentralized GPU compute and infrastructure-backed yield within the public markets. Under Mr. Miglino’s leadership, AGPU plans to...

Kaltura to Announce Financial Results for Fourth Quarter and Full Year 2025 on Monday, March 16, 2026

Written by Customer Service on February 9, 2026. Posted in Public Companies.

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) — Kaltura (Nasdaq: KLTR), the AI Video Experience Cloud, today announced it will release its fourth quarter and full-year financial results for the period ended December 31, 2025, after market close on Monday, March 16, 2026. Management will host a conference call to review the Company’s fourth quarter and full year 2025 financial results and discuss the financial outlook. Date: Monday, March 16, 2026 Time: 4:30 p.m. ET United States/Canada Toll Free: 1-877-407-0789 International Toll: +1-201-689-8562 A live and archived webcast will be available in the Investor Relations section of Kaltura’s website at: https://investors.kaltura.com/news-and-events/events About KalturaKaltura’s mission is to create and power AI-infused hyper-personalized video experiences that...

IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer

Written by Customer Service on February 9, 2026. Posted in Public Companies.

PhotoKate Rochlin, Ph.D., President & COONEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) — IN8bio (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ ) T cell therapies and T cell engagers for cancer and autoimmune diseases, today announced the promotion of Kate Rochlin, Ph.D., to President and Chief Operating Officer, effective immediately. Dr. Rochlin has served as IN8bio’s Chief Operating Officer since December 2021, following her tenure as Vice President and Associate Vice President of Operations and Innovation beginning in August 2020. In her expanded role, she will continue to oversee company operations as IN8bio advances its clinical and preclinical pipeline and prepares for its next phase of growth. “Kate has been instrumental in translating IN8bio’s strategy into disciplined...

XBP Global Named to Newsweek’s America’s Greatest Workplaces for Culture, Belonging & Community 2026

Written by Customer Service on February 9, 2026. Posted in Public Companies.

IRVING, Texas, Feb. 09, 2026 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a workflow automation leader that leverages decades of industry experience, a global footprint, and agentic AI to rethink business process automation and digital transformation, today announced that it has been recognized as one of Newsweek’s America’s Greatest Workplaces for Culture, Belonging & Community 2026, in partnership with Plant-A Insights Group. This recognition highlights XBP Global’s commitment to fostering an inclusive workplace culture where employees feel valued, heard, and connected, and where a strong sense of belonging and community underpins how teams collaborate and grow. The award acknowledges organizations that prioritize people-first cultures and create environments in which employees...

Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels

Written by Customer Service on February 9, 2026. Posted in Public Companies.

DURHAM, N.C., Feb. 09, 2026 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the recently adopted FY 2026 U.S. Department of Defense (DoD) Appropriations Act includes dedicated funding to support the evaluation and incorporation of biologic vascular repair technologies for the warfighters suffering from traumatic vascular injuries. The FY2026 National Defense Authorization Act (NDAA), enacted in December 2025, stated in report language that DoD should “integrate FDA-approved breakthrough vascular repair technologies in traumatic extremity arterial injury repair, providing an off-the-shelf, biologically active vascular conduit when autologous vein harvesting is not feasible.”...

Greenridge Global: Sapience AI Investment Represents a Big Deal for Society Pass Incorporated (Nasdaq: SOPA) Shareholders

Written by Customer Service on February 9, 2026. Posted in Public Companies.

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) — Greenridge Global LLC (“Greenridge”) issues equity research report on Society Pass Incorporated. (Nasdaq: SOPA) (the “Company”), Southeast Asia’s (SEA) next generation e-commerce ecosystem. Click Here for the English version and Click Here for the Chinese version (both on Society Pass website) to view the full Greenridge Global Equity Research Report. Summary Points:• Sapience Investment: Society Pass announced in late-January an $8.8 million investment in Sapience AI, a European-based GPU-as-a-Service provider. With access to Nvidia’s Blackwell chips, Sapience is developing smaller sized colocation data centres in Europe that customers can lease access to on a short-term or longer term basis for inference usage, or for fault-tolerant model training. Management believes this strategy will...

Flywire to Announce Fourth Quarter 2025 Results on February 24, 2026

Written by Customer Service on February 9, 2026. Posted in Public Companies.

BOSTON, Feb. 09, 2026 (GLOBE NEWSWIRE) — Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its fourth-quarter financial results will be released after market close on Tuesday, February 24, 2026. Flywire will host a conference call to discuss its fourth-quarter financial results at 5:00 pm ET the same day. Hosting the call will be Mike Massaro, CEO, Rob Orgel, President and COO, and Cosmin Pitigoi, CFO. The conference call will be webcast live from Flywire’s investor relations website at https://ir.flywire.com/. A replay will be available on the investor relations website following the call. About FlywireFlywire is a global payments enablement and software company. We combine our proprietary global payments network, next-generation payments platform, and vertical-specific...

BioSyent to Acquire Oral Science Inc.

Written by Customer Service on February 9, 2026. Posted in Mergers And Acquisitions.

Accretive Transaction with Combined Companies’ Pro-Forma Revenue in Excess of $70.00 Million and EBITDA(1) in Excess of $15.75 Million (TTM Sept 30, 2025) MISSISSAUGA, Ontario, Feb. 09, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture (TSXV): RX) announced today that it has entered into a Share Purchase Agreement (“SPA”) dated February 8, 2026 to acquire Oral Science Inc. (“Oral Science”), a privately-owned Canadian distributor of specialized healthcare products for dental hygiene and oral health based in Brossard, Quebec. THE TRANSACTION Pursuant to the SPA, BioSyent will acquire from the shareholders of Oral Science (the “Sellers”), in an arm’s length transaction, 100% of the issued and outstanding shares of Oral Science Inc. for a $25.5 million purchase price consisting of $22.5 million of cash and 234,192 BioSyent...

Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update

Written by Customer Service on February 9, 2026. Posted in Earnings Releases And Operating Results.

Company to host a webcast today at 8:30 am Eastern Time NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today reported financial results for its first quarter of fiscal 2026. “As we have entered 2026, we continue to progress our innovative clinical pipeline with particular focus on our lead candidate, oral blarcamesine in early Alzheimer’s disease. Based on our commitment to improving the lives of patients with neurological disorders, we remain excited about the therapeutic...

Transocean to Acquire Valaris

Written by Customer Service on February 9, 2026. Posted in Mergers And Acquisitions.

Creates the world’s highest-quality, highest-specification offshore drilling fleet Companies to host conference call today at 8 a.m. CT / 9 a.m. ET STEINHAUSEN, Switzerland and HAMILTON, Bermuda, Feb. 09, 2026 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) and Valaris Limited (NYSE: VAL) today announced the signing of a definitive agreement to combine the two companies under which Transocean will acquire Valaris in an all-stock transaction valued at approximately $5.8 billion (all currency in USD). The shareholding percentages of the combined company, on a fully diluted basis1, will be approximately 53% for Transocean and 47% for Valaris. The enterprise value of the pro forma company is approximately $17 billion. HighlightsCreates an industry leader with a diversified offshore fleet of 73 rigs, including 33 ultra-deepwater drillships,...

Month: February 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals